Literature DB >> 25560326

Sclerosis in bisphosphonate-related osteonecrosis of the jaws and its correlation with the clinical stages: study of 43 cases.

J V Bagan1, R M Cibrian2, J Lopez2, M Leopoldo-Rodado3, E Carbonell4, L Bagán5, J Utrilla6, C Scully7.   

Abstract

We analysed the degree of sclerosis in the different stages of bisphosphonate-related osteonecrosis of the jaws (BRONJ) and studied the relation between the grade of sclerosis, the clinical symptoms, and the depth of lucency. We compared 43 patients with mandibular BRONJ with a control group of 40 cases with no bony lesions. The presence of sclerotic bone, cortical irregularities, radiolucency, fragmentation or sequestration, periostitis, and narrowing of the mandibular canal were studied from computed tomographic (CT) scans using the program ImageJ 1.47v (National Institute of Health, Bethesda, USA) to measure the radiolucency, width of the cortices, and degree of sclerosis. Patients with BRONJ had more severe sclerosis than controls (p<0.01). There was also a significant difference among the different stages of BRONJ, with the highest values found in stage III (p=0.02). The degree of sclerosis differed according to sex, type of bisphosphonate, and the clinical characteristics such as pain, or suppuration, but not significantly so (p>0.05). We conclude that the degree of sclerosis increases with the clinical stage of BRONJ, and is correlated with the depth of lucency.
Copyright © 2014 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Osteonecrosis of the jaws; Radiographic findings; Sclerosis

Mesh:

Substances:

Year:  2015        PMID: 25560326     DOI: 10.1016/j.bjoms.2014.12.004

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  10 in total

Review 1.  Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.

Authors:  Valesca Sander Koth; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2016-05-31       Impact factor: 2.419

2.  Prevalence of radiographic findings on jaws exposed to antiresorptive therapy: a meta-analysis.

Authors:  Kamile Leonardi Dutra; Letícia Fernanda Haas; Glaucia S Zimmermann; Gilberto Melo; Mariana Comparotto Minamisako; Carlos Flores-Mir; Márcio Corrêa
Journal:  Dentomaxillofac Radiol       Date:  2018-11-07       Impact factor: 2.419

3.  Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy.

Authors:  Valesca S Koth; Maria A Figueiredo; Fernanda G Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2017-02-17       Impact factor: 2.419

4.  The impact of medication-related osteonecrosis of the jaws on the quality of life in cancer patients.

Authors:  Raquel-D'Aquino-Garcia Caminha; Patricia-Lopes Alcantara; Caroline-Gomes Carvalho; Verônica-Caroline-Brito Reia; Ana-Lucia-Alvares Capelozza; Paulo-Sérgio-da Silva Santos
Journal:  J Clin Exp Dent       Date:  2020-08-01

5.  Image findings of bisphosphonate related osteonecrosis of jaws comparing with osteoradionecrosis.

Authors:  Kenichi Obinata; Shinichi Shirai; Hitoshi Ito; Motoyasu Nakamura; Marco Carrozzo; Iain Macleod; Andrew Carr; Yutaka Yamazaki; Kanchu Tei
Journal:  Dentomaxillofac Radiol       Date:  2017-03-16       Impact factor: 2.419

Review 6.  Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis.

Authors:  H Devlin; J Greenwall-Cohen; J Benton; T L Goodwin; A Littlewood; K Horner
Journal:  Br Dent J       Date:  2017-11-17       Impact factor: 1.626

7.  Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.

Authors:  Kazuhito Tohashi; Motoki Nakabayashi; Isamu Kodani; Kazunori Kidani; Kazuo Ryoke
Journal:  Yonago Acta Med       Date:  2016-04-01       Impact factor: 1.641

8.  Medication related osteonecrosis of the jaw in osteoporotic vs oncologic patients-quantifying radiographic appearance and relationship to clinical findings.

Authors:  Kaycee Walton; Tristan R Grogan; Edwin Eshaghzadeh; Danny Hadaya; David A Elashoff; Tara L Aghaloo; Sotirios Tetradis
Journal:  Dentomaxillofac Radiol       Date:  2018-06-28       Impact factor: 2.419

Review 9.  Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.

Authors:  Pongsapak Wongratwanich; Kiichi Shimabukuro; Masaru Konishi; Toshikazu Nagasaki; Masahiko Ohtsuka; Yoshikazu Suei; Takashi Nakamoto; Rinus G Verdonschot; Tomohiko Kanesaki; Pipop Sutthiprapaporn; Naoya Kakimoto
Journal:  Dentomaxillofac Radiol       Date:  2021-01-15       Impact factor: 3.525

Review 10.  Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature.

Authors:  C Gavaldá; J-V Bagán
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-05-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.